Authors
A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, Sharon Spencer, Douglas Adkins, Andrew C Birkeland, David M Brizel, Paul M Busse, Jimmy J Caudell, Greg Durm, Carole Fakhry, Thomas Galloway, Jessica L Geiger, Maura L Gillison, Christine Glastonbury, Robert I Haddad, Wesley L Hicks, Ying J Hitchcock, Antonio Jimeno, Aditya Juloori, Michael Kase, Debra Leizman, Ellie Maghami, Loren K Mell, Bharat B Mittal, Harlan A Pinto, Katharine Price, James W Rocco, Cristina P Rodriguez, David Schwartz, Jatin P Shah, David Sher, Maie St John, He Wang, Gregory Weinstein, Francis Worden, Justine Yang Bruce, Sue S Yom, Weining Zhen, Sarah Montgomery, Susan D Darlow
Published in
Journal of the National Comprehensive Cancer Network : JNCCN. Volume 23. Issue 2. Pages 2-11.
Abstract
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.
PMID:
39938471
Bibliographic data and abstract were imported from PubMed on 13 Feb 2025.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1119
- Comments 0